Treatment of Hypothyroidism

B. Nygaard
{"title":"Treatment of Hypothyroidism","authors":"B. Nygaard","doi":"10.1093/med/9780198870197.003.0072","DOIUrl":null,"url":null,"abstract":"The goals for treatment of primary hypothyroidism are to restore euthyroidism with normalization of serum thyroid-stimulating hormone (TSH) and fT4 concentrations and to eliminate symptoms. Thyroxine, as levothyroxine sodium (L-T4), is the therapy of choice, and its use in most patients’ treatment is straightforward. In a minor patient group, persistent symptoms are present although thyroid function parameters are normalized. In these patients, it is pertinent to search for alternative explanations for the symptoms other than thyroid disease. A possible effect of a combination of L-T4 and L-T3 is disputed. Overtreatment with suppressed serum TSH must be avoided due to risks of cardiovascular disease, osteoporosis, and dementia.","PeriodicalId":130301,"journal":{"name":"Oxford Textbook of Endocrinology and Diabetes 3e","volume":"425 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oxford Textbook of Endocrinology and Diabetes 3e","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198870197.003.0072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The goals for treatment of primary hypothyroidism are to restore euthyroidism with normalization of serum thyroid-stimulating hormone (TSH) and fT4 concentrations and to eliminate symptoms. Thyroxine, as levothyroxine sodium (L-T4), is the therapy of choice, and its use in most patients’ treatment is straightforward. In a minor patient group, persistent symptoms are present although thyroid function parameters are normalized. In these patients, it is pertinent to search for alternative explanations for the symptoms other than thyroid disease. A possible effect of a combination of L-T4 and L-T3 is disputed. Overtreatment with suppressed serum TSH must be avoided due to risks of cardiovascular disease, osteoporosis, and dementia.
甲状腺功能减退症的治疗
原发性甲状腺功能减退的治疗目标是恢复甲状腺功能正常,血清促甲状腺激素(TSH)和fT4浓度正常化,并消除症状。甲状腺素,作为左旋甲状腺素钠(L-T4),是首选的治疗方法,它在大多数患者的治疗中使用是直接的。在少数患者组中,尽管甲状腺功能参数正常,但仍存在持续症状。在这些患者中,寻找甲状腺疾病以外的其他症状解释是相关的。L-T4和L-T3联合使用可能产生的影响存在争议。由于心血管疾病、骨质疏松和痴呆的风险,必须避免过度治疗抑制血清TSH。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信